md-medicaldata

Authors

 

Maja Samardžić Lukić¹, Milana Bosanac², Dejan Dobrijevic³, Natasa Kovač¹, Dragomir Ćuk⁴, Borko Milanović^2,5, Bojana Andrejić Višnjić<sup>2

1</sup>Institut za zdravstvenu zaštitu dece i omladine, Odeljenje za nefrologiju
²Medicinski fakultet Novi Sad, Univerzitet u Novom Sadu
³Institut za zdravstvenu zaštitu dece i omladine, Odeljenje za laboratorijsku dijagnostiku
⁴Klinički centar Vojvodine, Centar za histologiju i patologiju
⁵Institut za zdravstvenu zaštitu dece i omladine, Odeljenje za imunologiju, alergologiju i reumatologiju

 

UDK: 616.61-008.64:577.1

The paper was received / Rad primljen: 10.12.2021.

Accepted / Rad prihvaćen: 18.12.2021.

 

Correspondence to:

Bojana Andrejić Višnjić
Hajduk Veljkova 3, 21000 Novi Sad
tel: 063 1669300
e-mail: bojana.andrejic-visnjic@mf.uns.ac.rs

 

 

Sažetak

 

Broj osoba sa bubrežnim oštećenjem svakodnevno se povećava u svetu, i decenijama, u kliničkoj praksi, postoji potraga za idealnim markerom koji će rano detektovati bubrežno oštećenje. Jedan od markera u fazi istraživanja je i kidney injury molecule-1 (KIM-1), kome se može odrediti koncentracija u serumu i urinu ili stepen tkivne ekspresije. Većina autora se slaže da kod zdravih ososba nema KIM-1 u urinu i serumu. Koncentracije KIM-1 rastu brzo po oštećenju proksimalnih tubula (nakon 5-6h) i koreliraju sa padom jačine glomerulske filtracije i stepenom bubrežnog oštećenja. Ipak, nije razjašnjen mehanizam delovanja i da li je u stvari marker reparacije ili progresije oštećenja putem indukovanja inflamacije i fibroze.
Kod pedijatrisjke populacije, podaci su oskudni i nisu definisane referentne vrednosti, ali je ustanovljeno da su koncentracije KIM-1 niže kod dece određene etničke pripadnosti, sa pikom vrednosti u jutarnjim satima. 
Tkivna ekspresija KIM-1 je prisutna u svim stanjima i oboljenjima gde postoji oštećenje proksimalnih tubula, nezavisno od etiologije. Postoji mali broj studija o postojanju tj izostanku tkivne eskpresije kod zdravih tkiva, i daju suprotstavljene podatke. Još su ređa istraživanja ekspresije u fetalnim tkivima, ali podaci za sada govore da KIM-1 može biti indikator postojanja intrauterinog i/ili antemortem oštećenja usled hipoksije. Dalja istraživanja na fetalnom materijalu i tkivima pedijatrijske populacije je od esencijalnog značaja.

 

Ključne riječi

KIM1, bubrežno oštećenje, glomerulska filtracija

 

 

 

Abstract

 

The number of people with kidney diseases increases worldwide, and for decades, in clinical practice, there has been a search for the ideal marker that will detect kidney damage early. One of the markers in the research phase is kidney injury molecule-1 (KIM-1), which can be determined as serum and/or urine concentrations or the degree of tissue expression. Most authors agree that in healthy individuals there is no KIM-1 in urine and serum. Concentrations of KIM-1 increase rapidly after proximal tubules damage (after 5-6 h) and correlate with a decrease in glomerular filtration rate and the degree of renal damage. However, the mechanism of action has not been clarified and whether it is in fact a marker of reparation or progression of damage by inducing inflammation and fibrosis.
In the pediatric population, data are scarce, and no reference values ​​have been defined, but KIM-1 concentrations have been found to be lower in children of a certain ethnicity, with peak values ​​in the morning.
Tissue expression of KIM-1 is present in all conditions and diseases where there is damage to the proximal tubules, regardless of the etiology. There are a small number of studies on the existence or absence of tissue expression in healthy tissues, and they give conflicting data. Expression studies in fetal tissues are even rarer, but data for now suggest that KIM-1 may be an indicator of intrauterine and/or antemortem damage due to hypoxia. Further research on fetal material and tissues of the pediatric population is essential.

Key words:

KIM-1, kidney diseases, glomerular filtration

 

 

 

 

References:

1. Wasung ME, Chawla LS, Madero M. Biomarkers of renal function, which and when? Clinica Chimica Acta. 2015; Avg 350-7.
2. theisn.org [Internet]. Brussels: International Society of nephrology; c2021 [cited 2021 Dec 17]. Available from: https://www.theisn.org/.
3. Remuzzi G. Kidney Injury Molecule 1: In Search of Biomarkers of Chronic Tubulointerstitial Damage and Disease Progression. American Journal of Kidney Diseases. 2009; 53(1).
4. Ichimura T, Bonventre JV, Bailly V, et al. Kidney Injury Molecule-1 (KIM-1), a Putative Epithelial Cell. Adhesion Molecule Containing a Novel Immunoglobulin Domain, Is Up-regulated in Renal Cells after Injury. The journal of biological chemistry. 1998; 273(7).
5. Washino S, Hosohata K, Miyagawa T. Roles Played by Biomarkers of Kidney Injury in Patients with Upper Urinary Tract Obstruction. T. Int. J. Mol. Sci. 2020, 21(15).
6. Waanders F, Van Timmeren MM, Stegeman CA, et al. Kidney injury molecule-1 in renal disease. J Pathol 2010; Jan 220: 7–16.
7. Stolić RV. Novi biohemijski marker oštećenja bubrega. U Stolić RV, urednik. Propedevtika bubrežnih bolesti. Beograd, Ton plus; 2014. p:129-47.
8. Xu PC, Yhang JJ, Chen M, et al. Urinary kidney injury molecule-1 in patients with IgA nephropathy is closely associated with disease severity. Nephrol Dial Transplant. 2011;26(10).
9. Ogrizović SS. Značaj određivanja Kim-1 u tkivu i urinu bolesnika sa različitim bolestima bubrega. J Med Biochem. 2010; 29 (4).
10. Yin C, Wang N. Kidney injury molecule-1 in kidney disease. Renal Failure, 2016; 38(10).
11. Giacoman SL, Madero M. Biomarkers in chronic kidney disease, from kidney function to kidney damage. World J Nephrol. 2015; 4(1).
12. Song J, Yu J, Prayogo, et al. Understanding kidney injury molecule 1: a novel immune factor in kidney pathophysiology. Am J Transl Res. 2019;11(3).
13. Khreba NA, Abdelsalam M, Wahab AM, et al. Kidney Injury Molecule 1 (KIM-1) as an Early Predictor for Acute Kidney Injury in Post-Cardiopulmonary Bypass (CPB) in Open Heart Surgery Patients. International Journal of Nephrology. 2019; Mar: 1-6. 
14. Zhang PL, Rothblum LI, Han WK, et al. Kidney injury molecule-1 expression in transplant biopsies is a sensitive measure of cell injury. Kidney Int. 2008; 73(5).
15. Lim AI, Tang SCW, Lai KN et al. Kidney Injury Molecule-1:More Than Just an Injury Marker of Tubular Epithelial Cells? J. Cell. Physiol. 2013; Nov 917–24.
16. Waanders F, Vaidya VS, Van Goor H, et al. Effect of Renin-Angiotensin-Aldosterone System Inhibition, Dietary Sodium Restriction, and/or Diuretics on Urinary Kidney Injury Molecule 1 Excretion in Nondiabetic Proteinuric Kidney Disease: A Post Hoc Analysis of a Randomized Controlled Trial. American Journal of Kidney Diseases. 2009; 53(1).
17. McWilliam SJ, Antoine DJ, Sabbisetti V, et al. Reference intervals for urinary renal injury biomarkers KIM-1 and NGAL in healthy children. Biomark Med. 2014; 8(10).
18. Tomczak J, Wasilewska A, Milewski R. Urine NGAL and KIM-1 in children and adolescents with hyperuricemia. Pediatr Nephrol. 2013; May 28:1863–9.
19. Będzichowska A, Jobs K, Kloc M. et al. The Assessment of the Usefulness of Selected Markers in the Diagnosis of Chronic Kidney Disease in Children. Biomarker Insights, 2021; Apr  16: 1–9.
20. Han WK, Bailly V, Abichandani R, et al. Kidney Injury Molecule-1 (KIM-1): A novel biomarker for human renal proximal tubule injury. Kidney International. 2002; Mar 237–44.
21. Nogare AL, Veronese FV, Carpio VN, et al. Kidney injury molecule-1 expression in human kidney transplants with interstitial fibrosis and tubular atrophy. BMC Nephrology. 2015; 16(19).
22. Karmakova TA, Sergeeva NS, Kanukoev KY, et al. Kidney Injury Molecule 1 (KIM-1): a Multifunctional Glycoprotein and Biological Marker.Sovrem Tekhnologii Med. 2021;13(3).
23. Schroppel B, Krüger B, Walsh L, Yeung M, Harris S, Garrison K, et al. Tubular Expression of KIM-1 Does not Predict Delayed Function After Transplantation. J Am Soc Nephrol. 2010;21:536–42.
24. Huo W, Zhang K, Nie Z, Li Q, Jin F. Kidney injury molecule-1 (KIM-1): a novel kidney specific injury molecule playing potential double-edged functions in kidney injury. Transplant Rev. 2010;24:143–6.
25. van Timmeren MM, van den Heuvel MC, Bailly V, Bakker SJ, van Goor H, Stegeman CA. Tubular kidney injury molecule-1 (KIM-1) in human renal disease. J Pathol. 2007;212:209–17.
26. Yin W, Zhang PL, Mackins JK. Kidney injury molecule-1 identifies antemortem injury in postmortem adult and fetal kidney. Am J Physiol Renal Physiol. 2018; 315(6).
27. Humphreys BD, Xu F, Sabbisetti V, Grgic I, Naini SM, Wang N, et al. Chronic epithelial kidney injury molecule-1 expression causes murine kidney fibrosis. J Clin Invest. 2013;123:4023–35.
28. Lingadahalli S. Activated neutrophils mediate kim-1 shedding and renal remodelling. Bachelor of Medicine: Bachelor of Surgery Rajiv Gandhi University of Health Sciences; 2009.
29. Vogel MJ, Mustroph J, Staudner ST, et al. Kidney injury molecule‑1: potential biomarker of acute kidney injury and disease severity in patients with COVID‑19. Journal of Nephrology. 2021; 34(4).
    

PDF: 12-MD-Vol 13 No 3-4 Sept-Dec 2021_Samardžić Lukić et al.pdf